New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Marker Therapeutics, Inc.
MRKR
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

37M

Biotechnology

Next Earning date - 14 Nov 2024

37M

Biotechnology

Next Earning date - 14 Nov 2024

4.15USD
Shape-0.36 ( -8.08%)
Market Open
favorite-chart

Relative Strenght

94
favorite-chart

Volume Buzz

7%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

33%

Quote Panel

Shape
Updated October 24, 2024
1W 17.77 % 1M 60.67 % 3M -21.64 % 1Y 50.74 %

Key Metrics

Shape
  • Market Cap

    36.99M


  • Shares Outstanding

    8.92M


  • Share in Float

    6.45M


  • Dividende

    0


  • Earning Date

    14 Nov 2024


  • Price Target

    4.1454


  • Average Volume

    35354


  • Beta

    1.542


  • Range

    2.4-6.16


  • Industry

    Biotechnology


  • Website

    https://www.markertherapeutics.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

9.92x

P/S Ratio

3.81x

P/B Ratio

0.0

Debt/Equity

-276.5%

Net Margin

$-1.1

EPS

How MRKR compares to sector?

P/E Ratio

Relative Strength

Shape

MRKR

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$13M

Shape969%

2025-Revenue

$1.46

Shape-484%

2025-EPS

$13M

Shape-442%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Cantor Fitzgerald

initialise

Previous: Not converted

2021-03-21

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.80
vs -1.20

Q4.22

arrow
arrow

N/A

-0.48
vs -1.20

Q1.23

arrow
arrow

N/A

-0.57
vs -1.20

Q2.23

arrow
arrow

N/A

-0.47
vs -1.10

Q3.23

arrow
arrow

N/A

-0.34
vs -0.80

Q4.23

arrow
arrow

N/A

-0.48
vs -0.48

Q1.24

arrow
arrow

N/A

-0.27
vs -0.57

Q2.24

arrow
arrow

N/A

-0.25
vs -0.47

Q3.24

arrow
arrow

N/A

-0.39
vs -0.34

Q4.24

arrow
arrow

N/A

-0.53
vs -0.48

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

NA

3M  vs NA

Q4.22

arrow
arrow

+388%

6.1M  vs 1.2M

Q1.23

arrow
arrow

+263%

3.5M  vs 964K

Q2.23

arrow
arrow

-4%

762.7K  vs 791K

Q3.23

arrow
arrow

-91%

257.6K  vs 3M

Q4.23

arrow
arrow

-83%

1.1M  vs 6.1M

Q1.24

arrow
arrow

-64%

1.2M  vs 3.5M

Q2.24

arrow
arrow

+53%

1.2M  vs 762.7K

Q3.24

arrow
arrow

+288%

1M  vs 257.6K

Q4.24

arrow
arrow

-5%

1M  vs 1.1M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-31%

-0.31
vs -0.33

Q4.22

arrow
arrow

-20%

-0.20
vs -0.31

Q1.23

arrow
arrow

-31%

-0.31
vs -0.20

Q2.23

arrow
arrow

+13%

0.13
vs -0.31

Q3.23

arrow
arrow

-18%

-0.18
vs 0.13

Q4.23

arrow
arrow

-19%

-0.19
vs -0.18

Q1.24

arrow
arrow

-20%

-0.20
vs -0.19

Q2.24

arrow
arrow

-23%

-0.23
vs -0.20

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

38

38
vs 43

-12%

Q4.22

arrow
arrow

43

43
vs 38

13%

Q1.23

arrow
arrow

2

2
vs 43

-95%

Q2.23

arrow
arrow

1

1
vs 2

-50%

Q3.23

arrow
arrow

1

1
vs 1

NA

Q4.23

arrow
arrow

1

1
vs 1

NA

Q1.24

arrow
arrow

1

1
vs 1

NA

Q2.24

arrow
arrow

1

1
vs 1

NA

Earnings Growth

Latest News